Opei Kwafo Adarkwa

Dr. Opei Kwafo Adarkwa

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YNYvonne Ayerki Nartey
Yvonne Ayerki Nartey
RORafiq Okine
Rafiq Okine
ASAtsu Seake-Kwawu
Atsu Seake-Kwawu
GGGeorgia Ghartey
Georgia Ghartey
YAYaw Karikari Asamoah
Yaw Karikari Asamoah
DODorcas Obiri-Yeboah
Dorcas Obiri-Yeboah
The current burden of Hepatitis C virus infection and the availability of HCV-related services in Ghana are not well described. Previous estimates on HCV seroprevalence in the country are outdated. This study investigated the HCV seroprevalence and testing and treatment capacity in Ghana. A multi-centre cross-sectional study was conducted in which laboratory and blood bank registers from 17 public healthcare institutions in Ghana were reviewed. A survey on cost and availability of HCV-related testing and treatment was also performed. Crude and pooled estimates of HCV seroprevalence, frequency and median cost of available diagnostic tests and medicines were described. The crude HCV seroprevalence was 2.62% (95% CI 2.53–2.72) and the pooled estimate was 4.58% (95% CI 4.06–5.11) among 103,609 persons tested in laboratories. Age (OR 1.02 95% CI 1.01–1.02) and male sex (OR 1.26 95% CI 1.08–1.48) were predictors of a positive anti-HCV RDT test. Northern administrative regions in Ghana had the highest HCV seroprevalence ranging from 8.3–14.4%. Among 55, 458 potential blood donors, crude HCV seroprevalence was 3.57% (95% CI 3.42–3.72). Testing was through Rapid Diagnostic Test (RDT) kits in most facilities, and only 2 of 17 centres were performing HCV RNA testing. The median cost of an anti-HCV RDT test was $0.97 (0–1.61) and $3.23 (1.61–7.58) for persons with and without government health insurance respectively. The median cost of a 12-week course of the pan-genotypic direct-acting antiviral therapy sofosbuvir-daclatasvir was $887.70. In conclusion, there are significant regional differences in HCV burden across Ghana. Limited access to and cost of HCV RNA and DAA therapy hinders testing and treatment capability, and consequently HCV elimination efforts. A national HCV program supported with a sustainable financing plan is required to accelerate HCV elimination in Ghana.

12 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
COChristian Obirikorang
Christian Obirikorang
DODerick Nii Mensah Osakunor
Derick Nii Mensah Osakunor
BNBenedict Ntaadu
Benedict Ntaadu
OAOpei Kwafo Adarkwa
Opei Kwafo Adarkwa
HAART is anticipated to result in an increase in long-term survival, but may present with the development of associated complications. The aim of this study was to assess the renal function of HIV-infected patients on antiretroviral therapy. A case-control study (January to May 2013) conducted at the Suntreso Government Hospital, Kumasi, Ghana. A total of 163 HIV-infected patients (mean age 39.9±10.22) were studied, of which 111 were on HAART (HIV-HAART) and 52 were not (HIV-Controls). Serum urea, creatinine, potassium, sodium, chloride and CD4 counts were measured with the determination of eGFR (CKD-EPI and MDRD). Data was analysed using GraphPad Prism. The Chi-square, t-test, one-way ANOVA and Spearman's correlation were used. P values <0.05 were considered significant. Mean CD4 count of HIV-Controls was higher than that of HIV-HAART but was not significant (p = 0.304). But for sodium levels which were higher in HIV-Controls (p = 0.0284), urea (p = 0.1209), creatinine (p = 0.7155), potassium (p = 0.454) and chloride (p = 0.6282) levels did not differ significantly between both groups. All serum biochemical parameters did not differ significantly, irrespective of duration on therapy and CD4 counts. Based on regimen, sodium, chloride, urea and creatinine did not differ significantly between TDF, EVF and NVP-based therapies. Prevalence of CKD (eGFR <60 ml/min/1.73 m2) in the total population was 9.9% and 3.7% with the MDRD and EPI-CKD equations respectively. Renal insufficiency remains prevalent in HIV patients. Changes in renal function occur in HIV infection and over the course of HAART but the difference at either stage is not significant. This suggests the role of HIV infection, HAART and the presence of traditional risk factors but not HAART in itself, in renal dysfunction. We however recommend a close monitoring of patients before and during HAART, to aid in evaluating drug combinations and implement dose modifications when necessary.

27 July 2024 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
OAOpei Kwafo Adarkwa
Opei Kwafo Adarkwa
TATheophilus Adu-Bredu
Theophilus Adu-Bredu
KDK.M. Rex Djokoto
K.M. Rex Djokoto

13 December 2024 in Nursing Open
Verified
Journal Article
Open access
OAOpei Kwafo Adarkwa
Opei Kwafo Adarkwa
DODouglas Aninng Opoku
Douglas Aninng Opoku
RLRoderick E. Larsen‐Reindorf
Roderick E. Larsen‐Reindorf
EOEllis Owusu‐Dabo
Ellis Owusu‐Dabo
BBBenedicta Boamah
Benedicta Boamah
AMAliyu Mohammed
Aliyu Mohammed
Aim: To determine the prevalence and factors associated with antenatal depression risk among pregnant women attending antenatal care at a district hospital in Kumasi, Ghana.Study Design: This was a hospital‐based cross‐sectional study.Methods: A questionnaire was used to collect data from 207 pregnant women attending antenatal care at Manhyia District Hospital from September 2020 to November 2020. The Edinburgh Postnatal Depression Scale was used to screen for depression risk. Factors associated with antenatal depression risk were evaluated using logistic regression analysis.Results: The prevalence of antenatal depression risk was 13.5% (n = 28). The most commonly reported intimate partner violence that contributed to depression risk was physical abuse (16.9%, n = 35). Factors such as physical abuse (AOR = 3.36, 95% CI: 1.13–10.02), domestic abuse (AOR = 3.88, 95% CI: 1.01–15.00) and self‐harm ideation (AOR = 8.50, 95% CI: 2.44–29.63) were associated with increased odds of antenatal depression risk among the study participants.Conclusion: This study revealed a low prevalence of antenatal depression risk. Extra attention should be given to factors such as intimate partner violence (domestic and physical abuse) and self‐harm ideation. Also, screening all pregnant women, especially those with risk factors, for the risk of antenatal depression and early diagnosis and treatment of the risk of depression are important for the health of the mother, fetus and newborn.

22 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RDRex Mawuli Kwadjo Djokoto
Rex Mawuli Kwadjo Djokoto
IBIRENE BANDOH
IRENE BANDOH
SWSAM-AWORTWI WILFRED
SAM-AWORTWI WILFRED
NBNana Addo Boateng
Nana Addo Boateng
WAWilliam Addison
William Addison
ATAugustine Tawiah
Augustine Tawiah
Background: Obstetric haemorrhage remains an important cause of maternal death and severe morbidity. Outcomes depend on timely recognition, resuscitation, referral, access to blood and essential treatment, and critical care. This study described the clinical characteristics, documented haemorrhage diagnoses, and ICU outcomes of women admitted with obstetric haemorrhage to the main intensive care unit (ICU) of Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. Methods: This retrospective cohort analysis included 79 women with an obstetric haemorrhage-related diagnosis documented in ICU records, drawn from 344 obstetric ICU admissions between 17 July 2022 and 16 July 2023. Demographic and clinical characteristics, ICU treatments, and outcomes were summarized. Survivors and non-survivors were compared using the Wilcoxon rank-sum test and the chi-square or Fisher exact test, as appropriate. Only unadjusted comparisons are reported because the patient-level dataset required for a prespecified admission-only model was not available for analysis. Results: Among 344 obstetric admissions to KATH’s main ICU, 79 women (23.0%) had documented obstetric haemorrhage and were included. Postpartum haemorrhage was the most common diagnosis (32/79, 40.5%), followed by abruptio placentae (18/79, 22.8%) and uterine rupture (12/79, 15.2%). Forty-four women died in the ICU (55.7%). The GCS variable, labelled “admission GCS” in the source dataset, was lower among non-survivors than survivors (median 8 vs. 15; p < 0.001), as was diastolic blood pressure (71.5 vs. 86 mmHg; p = 0.010). Mechanical ventilation was more frequent among non-survivors (70.5% vs. 40.0%; p = 0.013), while hospital stay was shorter (4 vs. 9 days; p < 0.001). GCS measurement timing could not be verified; treatment and length-of-stay differences describe post-admission care and course. Conclusions: Among women admitted to a general mixed ICU with documented obstetric haemorrhage, ICU mortality was high and postpartum haemorrhage was the most common diagnosis. Lower recorded GCS among non-survivors was an unadjusted descriptive finding; the source dataset’s GCS timing could not be confirmed, and no adjusted prognostic effect can be inferred. Prospective studies with verified admission measures, explicit case criteria, and treatment timing are needed.

4 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
RDRex Mawuli Kwadjo Djokoto
Rex Mawuli Kwadjo Djokoto
IBIRENE BANDOH
IRENE BANDOH
SWSAM-AWORTWI WILFRED
SAM-AWORTWI WILFRED
NBNana Addo Boateng
Nana Addo Boateng
WAWilliam Addison
William Addison
ATAugustine Tawiah
Augustine Tawiah
Background: Hypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality and frequently require intensive care when severe. This study aimed to describe the clinical characteristics, critical care interventions, and maternal outcomes of women admitted with severe HDP and to compare women with eclampsia and postpartum eclampsia. Methods: We retrospectively analyzed 142 women admitted with severe HDP to the main intensive care unit of Komfo Anokye Teaching Hospital, Ghana. Clinical characteristics, critical care interventions, and maternal outcomes were described, and women with eclampsia (n = 112) were compared with those with postpartum eclampsia (n = 25). Results: Among the 142 women, 112 (78.9%) had eclampsia and 25 (17.6%) had postpartum eclampsia. Overall, 65 women (45.8%) died during ICU admission. Women with postpartum eclampsia had significantly higher parity (median 3 vs. 2, P = 0.047) and lower Glasgow Coma Scale scores at admission (median 8 vs. 14, P < 0.001) than women with eclampsia. No significant differences were observed between the two groups in critical care interventions, length of hospital stay, or ICU mortality. Conclusions: Women with postpartum eclampsia had distinct clinical features, including higher parity and greater neurological impairment at presentation, although maternal outcomes were similar to those of women with eclampsia. Further studies are needed to understand better severe hypertensive disorders requiring intensive care.